XTX Topco’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

XTX Topco’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,829	Closed	-$66K	–	1026
2021 Q4	$66K	Buy	+3,829	New	+$80.1K	0.04%	532

Other funds holding ZIVO

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

XTX Topco's ZIVO Position: Q1 2022 in Review

XTX Topco sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q1 2022, closing a stake of 3,829 shares — an estimated $66K sold.

XTX Topco first reported a position in ZIVO in Q4 2021 and held it in 1 quarter. The position peaked at $66K in Q4 2021. 12 funds tracked by Wall St. Rank hold ZIVO as of Q1 2022.

XTX Topco reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
XTX Topco sold 3,829 Zivo Bioscience, Inc. Common Stock shares in Q1 2022, an estimated $66K.
XTX Topco first reported a position in Zivo Bioscience, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
XTX Topco's Zivo Bioscience, Inc. Common Stock position peaked at $66K in Q4 2021.
12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q1 2022.

Based on XTX Topco's 13F filing for Q1 2022, filed 13 May 2022.